Shuttle Pharmaceuticals Holdings, Inc. (SHPH) stock
SHPHNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Sep 24, 2026Score 5/30
$3.82−0.48 (-11.09%)
Close on Nov 18, 2026Market cap $3.83MP/E –Yield –
Shuttle Pharmaceuticals operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Shuttle Pharmaceuticals's operating income for the twelve months ending Jun 30, 2026 was -$11.22M. For fiscal 2025 it was -$11.92M. The highest annual figure on record is -$1.74M in fiscal 2021.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$11.92M | – |
| FY2024 | Dec 31, 2024 | -$7.70M | – |
| FY2023 | Dec 31, 2023 | -$5.89M | – |
| FY2022 | Dec 31, 2022 | -$2.34M | – |
| FY2021 | Dec 31, 2021 | -$1.74M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$3.95M | – |
| Q1 FY2026 | Mar 31, 2026 | -$2.22M | – |
| Q4 FY2025 | Dec 31, 2025 | -$2.79M | – |
| Q3 FY2025 | Sep 30, 2025 | -$2.27M | – |
| Q2 FY2025 | Jun 30, 2025 | -$3.91M | – |
| Q1 FY2025 | Mar 31, 2025 | -$2.95M | – |
| Q4 FY2024 | Dec 31, 2024 | -$1.78M | – |
| Q3 FY2024 | Sep 30, 2024 | -$3.05M | – |
| Q2 FY2024 | Jun 30, 2024 | -$1.48M | – |
| Q1 FY2024 | Mar 31, 2024 | -$1.38M | – |
| Q4 FY2023 | Dec 31, 2023 | -$1.28M | – |
| Q3 FY2023 | Sep 30, 2023 | -$1.60M | – |
| Q2 FY2023 | Jun 30, 2023 | -$1.47M | – |
| Q1 FY2023 | Mar 31, 2023 | -$1.54M | – |
| Q4 FY2022 | Dec 31, 2022 | -$530.34K | – |
| Q3 FY2022 | Sep 30, 2022 | -$821.47K | – |
| Q2 FY2022 | Jun 30, 2022 | -$353.63K | – |
| Q1 FY2022 | Mar 31, 2022 | -$638.40K | – |
| Q4 FY2021 | Dec 31, 2021 | -$988.54K | – |
| Q3 FY2021 | Sep 30, 2021 | -$242.12K | – |
See a number that looks wrong?